By Mandy Jackson
Daily Journal Staff Writer
A dramatic increase in drug recalls has prompted investigations and new legislation to strengthen regulators' ability to monitor drug quality and recall tainted products.
The move could provide new ammunition for plaintiffs in drug-related product liability cases.
The Drug Safety and Accountability Act of 2010, introduced in August by Sen. Michael Bennet, D-Colo., wo...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In